Schiff M, et al. - This research sought a better characterization of the natural history of phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG). It was determined that PMM2-CDG clinical phenotype was heterogeneous with regard to the clinical course. It did not display any clear division between the neurological and visceral presentations.